(Q54544255)
Statements
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study). (English)
E Aranda
J L Manzano
F Rivera
M Galán
M Valladares-Ayerbes
M J Safont
M J Mendez
A Irigoyen
A Arrivi
J Sastre
9 December 2011
23
7
1919-1925